{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:30:13Z","timestamp":1772026213996,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Neuroimaging, Longhua District, Shenzhen","award":["Shen Long Hua Ke Chuang KeJi Zi (2022) No. 7"],"award-info":[{"award-number":["Shen Long Hua Ke Chuang KeJi Zi (2022) No. 7"]}]},{"name":"Shenzhen Fundamental Research Program (Natural Science Foundations), General Programe for Fundamental Research","award":["JCYJ20210324142404012"],"award-info":[{"award-number":["JCYJ20210324142404012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01792-0","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T09:48:04Z","timestamp":1736761684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating machine learning with mendelian randomization for unveiling causal gene networks in glioblastoma multiforme"],"prefix":"10.1007","volume":"16","author":[{"given":"Lixin","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"issue":"3","key":"1792_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/jcrt.jcrt_1324_21","volume":"18","author":"G Chandrasekar","year":"2022","unstructured":"Chandrasekar G, Bansal VS, Panigrahi M, et al. An overview of targets and therapies for glioblastoma multiforme. J Cancer Res Ther. 2022;18(3):591\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"1792_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000531319","volume":"108","author":"A Czarnywojtek","year":"2023","unstructured":"Czarnywojtek A, Borowska M, Dyrka K, et al. Glioblastoma multiforme: the latest diagnostics and treatment techniques. Pharmacology. 2023;108(5):423\u201331.","journal-title":"Pharmacology"},{"key":"1792_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.603911","volume":"11","author":"B Huang","year":"2020","unstructured":"Huang B, Li X, Li Y, et al. Current immunotherapies for glioblastoma multiforme. Front Immunol. 2020;11: 603911.","journal-title":"Front Immunol"},{"issue":"9","key":"1792_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s12032-022-01708-w","volume":"39","author":"DJ McMahon","year":"2022","unstructured":"McMahon DJ, Gleeson JP, O\u2019Reilly S, et al. Management of newly diagnosed glioblastoma multiforme: current state of the art and emerging therapeutic approaches. Med Oncol. 2022;39(9):129.","journal-title":"Med Oncol"},{"issue":"1","key":"1792_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","volume":"9","author":"A Bikfalvi","year":"2023","unstructured":"Bikfalvi A, da Costa CA, Avril T, et al. Challenges in glioblastoma research: focus on the tumor microenvironment. Trends in cancer. 2023;9(1):9\u201327.","journal-title":"Trends in cancer"},{"issue":"9","key":"1792_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/cells10092257","volume":"10","author":"M Dapash","year":"2021","unstructured":"Dapash M, Hou D, Castro B, et al. The interplay between glioblastoma and its microenvironment. Cells. 2021;10(9):2257.","journal-title":"Cells"},{"issue":"8","key":"1792_CR7","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.3390\/ijms24087047","volume":"24","author":"JI Erices","year":"2023","unstructured":"Erices JI, Bizama C, Niechi I, et al. Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets. Int J Mol Sci. 2023;24(8):7047.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1792_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ajco.12756","volume":"14","author":"AO Sasmita","year":"2018","unstructured":"Sasmita AO, Wong YP, Ling APK. Biomarkers and therapeutic advances in glioblastoma multiforme. Asia Pac J Clin Oncol. 2018;14(1):40\u201351.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"3","key":"1792_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12032-018-1083-x","volume":"35","author":"GS Stoyanov","year":"2018","unstructured":"Stoyanov GS, Dzhenkov D, Ghenev P, et al. Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment. Med Oncol. 2018;35(3):27.","journal-title":"Med Oncol"},{"issue":"11","key":"1792_CR10","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.15252\/emmm.201302627","volume":"6","author":"SK Carlsson","year":"2014","unstructured":"Carlsson SK, Brothers SP, Wahlestedt C. Emerging treatment strategies for glioblastoma multiforme. EMBO Mol Med. 2014;6(11):1359\u201370.","journal-title":"EMBO Mol Med"},{"issue":"6","key":"1792_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/bib\/bbac386","volume":"23","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang N, Wu W, et al. Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma. Brief Bioinformat. 2022;23(6):386.","journal-title":"Brief Bioinformat."},{"issue":"6","key":"1792_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1226","volume":"2","author":"J Valdebenito","year":"2019","unstructured":"Valdebenito J, Medina F. Machine learning approaches to study glioblastoma: a review of the last decade of applications. Cancer Reports. 2019;2(6): e1226.","journal-title":"Cancer Reports"},{"issue":"2","key":"1792_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/metabo13020161","volume":"13","author":"ZD Neil","year":"2023","unstructured":"Neil ZD, Pierzchajlo N, Boyett C, et al. Assessing metabolic markers in glioblastoma using machine learning: a systematic review. Metabolites. 2023;13(2):161.","journal-title":"Metabolites"},{"issue":"5","key":"1792_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bfgp\/elad002","volume":"22","author":"HB Arteaga-Arteaga","year":"2023","unstructured":"Arteaga-Arteaga HB, Candamil-Cort\u00e9s MS, Breaux B, et al. Machine learning applications on intratumoral heterogeneity in glioblastoma using single-cell RNA sequencing data. Brief Funct Genomics. 2023;22(5):428\u201341.","journal-title":"Brief Funct Genomics"},{"key":"1792_CR15","doi-asserted-by":"publisher","first-page":"1122570","DOI":"10.3389\/fimmu.2023.1122570","volume":"14","author":"Y Dong","year":"2023","unstructured":"Dong Y, Xu C, Su G, et al. Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation. Front Immunol. 2023;14:1122570.","journal-title":"Front Immunol"},{"key":"1792_CR16","doi-asserted-by":"publisher","first-page":"1082974","DOI":"10.3389\/fimmu.2023.1082974","volume":"14","author":"B Zhang","year":"2023","unstructured":"Zhang B, Xie L, Liu J, et al. Construction and validation of a cuproptosis-related prognostic model for glioblastoma. Front Immunol. 2023;14:1082974.","journal-title":"Front Immunol"},{"issue":"1","key":"1792_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41401-021-00752-y","volume":"43","author":"LW Ren","year":"2022","unstructured":"Ren LW, Li W, Zheng XJ, et al. Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle. Acta Pharmacol Sin. 2022;43(1):194\u2013208.","journal-title":"Acta Pharmacol Sin"},{"key":"1792_CR18","doi-asserted-by":"publisher","first-page":"4246703","DOI":"10.1155\/2018\/4246703","volume":"2018","author":"Q Yang","year":"2018","unstructured":"Yang Q, Wang R, Wei B, et al. Candidate biomarkers and molecular mechanism investigation for glioblastoma multiforme utilizing WGCNA. Biomed Res Int. 2018;2018:4246703.","journal-title":"Biomed Res Int"},{"issue":"1","key":"1792_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12944-023-01988-9","volume":"23","author":"L Dai","year":"2024","unstructured":"Dai L, Yuan W, Jiang R, et al. Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis. Lipids Health Dis. 2024;23(1):23.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"1792_CR20","doi-asserted-by":"publisher","first-page":"9085","DOI":"10.18632\/aging.202789","volume":"13","author":"B Zhang","year":"2021","unstructured":"Zhang B, Xu C, Liu J, et al. Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients. Aging. 2021;13(6):9085\u2013107.","journal-title":"Aging"},{"issue":"3","key":"1792_CR21","first-page":"2591","volume":"16","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wu X, Xu C, et al. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures. Aging. 2024;16(3):2591\u2013616.","journal-title":"Aging"},{"issue":"2","key":"1792_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41416-020-01083-1","volume":"124","author":"CN Saunders","year":"2021","unstructured":"Saunders CN, Cornish AJ, Kinnersley B, et al. Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study. Br J Cancer. 2021;124(2):447\u201354.","journal-title":"Br J Cancer"},{"key":"1792_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fgene.2018.00525","volume":"9","author":"AE Howell","year":"2018","unstructured":"Howell AE, Zheng J, Haycock PC, et al. Use of mendelian randomization for identifying risk factors for brain tumors. Front Genet. 2018;9:525.","journal-title":"Front Genet"},{"issue":"1","key":"1792_CR24","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41598-021-82169-5","volume":"11","author":"JW Robinson","year":"2021","unstructured":"Robinson JW, Martin RM, Tsavachidis S, et al. Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility. Sci Rep. 2021;11(1):2329.","journal-title":"Sci Rep"},{"key":"1792_CR25","doi-asserted-by":"publisher","first-page":"1255611","DOI":"10.3389\/fimmu.2023.1255611","volume":"14","author":"F Yasinjan","year":"2023","unstructured":"Yasinjan F, Xing Y, Geng H, et al. Immunotherapy: a promising approach for glioma treatment. Front Immunol. 2023;14:1255611.","journal-title":"Front Immunol"},{"key":"1792_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-59038-3_1","volume":"1296","author":"M Butler","year":"2020","unstructured":"Butler M, Prasad S, Srivastava SK. Targeting glioblastoma tumor microenvironment. Adv Exp Med Biol. 2020;1296:1\u20139.","journal-title":"Adv Exp Med Biol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01792-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T21:42:55Z","timestamp":1736804575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01792-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1792"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01792-0","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent participation"}},{"value":"The authors declare that they have no conflicts of interest to report regarding the present study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}